Companies in ECG Devices Market Analysis 2031

ECG Devices Market Outlook 2031

• The globalECG devices market was valued at US$ 5.6 Bn in 2021
• It is projected to grow at a CAGR of 3%from 2022 to 2031
• The globalECG devices market is anticipated to reach US$ 11.6 Bn by the end of 2031

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61827

Overview of Global ECG Devices Market

ECG device is generally used alongside other tests to help diagnose and monitor conditions affecting the heart. It is a painless, non-invasive source that helps diagnose many common heart-related issues. Increase in geriatric population, unhealthy diet, and obesity among various age groups are projected to propel the ECG devices market in the near future.

Rise in Prevalence of Cardiovascular Diseases across Globe to Drive Market

The prevalence of cardiovascular diseases is high across the globe. Cardiovascular diseases include a group of disorders of blood vessels and the heart such as congenital heart disease, rheumatic heart disease, coronary heart disease, and cerebrovascular disease. Increase in prevalence of cardiovascular diseases in developing countries can be linked to the rise in incidence of hypertension; increase in smoking, and growth in obesity caused by sedentary lifestyle. Presence of a large patient pool suffering from cardiovascular diseases is projected to drive the global ECG devices market during the forecast period.

Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=61827

Increase in Need for Cardiovascular Monitoring among Aging Population to Boost Market

Aging is one of the key factors responsible for the increase in the incidence of disorders such as hypertension and high blood cholesterol level. This is likely to drive the demand for cardiovascular monitoring and diagnostic devices, such as ECG, that enable quick diagnosis of the disease and monitoring of patients.

According to a study published in the American Journal of Medicine, the U.S. population is aging rapidly. Increase in life expectancy is likely to result in a doubling of the population aged 65 years or above from 40 million people in 2010 to 81 million by 2040. The mortality rate is the highest in Eastern Europe and middle-income countries. Overall CVD death rates are higher in low- and middle-income countries than those in developed countries. Increase in population aged 65 years or above augments the demand for diagnostic and monitoring devices including ECG devices. This is anticipated to drive the global ECG devices market during the forecast period.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=61827

Growth in Demand for Resting ECG Procedures among Patients to Augment Market

The resting ECG systems segment dominated the global ECG devices market, accounting for a market share of around 50% in 2021. Higher share of the segment can be ascribed to the better exchange of information through Cardiovascular Information Systems (CVIS) and Electronic Health Record (EHRs), which simplify ECG workflow and reduce the complexity associated with custom integration, and rise in usage of resting ECG systems in hospitals, clinics, and ambulatory surgical centers. Development and launch of technologically advanced electrocardiogram devices – recently developed ECG monitoring systems are designed to improve workflow and simplify operation – is expected to propel the segment during the forecast period. Holter monitoring system and stress ECG system are also rapidly growing segments based on technology type.

ECG Devices Primarily Being Used in Hospitals to Drive Hospitals Segment

Based on end-user, the hospitals segment is projected to account for dominant share of the global ECG devices market from 2022 to 2031. The ambulatory surgical centers segment is also anticipated to grow at a high CAGR from 2022 to 2031. Major share of the hospitals segment can be ascribed to the increase in usage of ECG devices in cardiac settings across hospitals, as an electrocardiogram is the most common diagnostic tool in the cardiac department. It is also the most frequently performed test in hospitals. Increase in preference for ambulatory surgical centers, as these are high-quality, cost-effective settings for cardiac patients and cardiovascular procedures, is expected to propel the ambulatory surgical centers segment during the forecast period.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=61827

Analysis of Key Players in Global ECG Devices Market

The global ECG devices market is consolidated, with a few key players accounting for a major share. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include GE Healthcare, Nihon Kohden Corporation, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Spacelabs Healthcare (OSI Systems, Inc.), Fukuda Denshi Co., Ltd, SCHILLER AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and CompuMed, Inc.

Key Developments in Global ECG Devices Market

• In April 2022, Biotricity officially launched the commercial sales of its FDA-cleared wireless wearable cardiac monitoring device, Biotres. The product has been available for pre-order to physicians, medical offices, hospitals, and individual use since late February 2022.
• In January 2022, Philips announced the industry’s first full-service, at-home 12-lead electrocardiogram (ECG) solution for usage in decentralized clinical trials. The clinical-grade solution is the company’s most sophisticated patient-centric ECG product, combining data readings that are equivalent to clinical, site-based ECGs with Philips’ leading cloud-based data gathering and analysis capabilities. This latest addition to Philips’ digitally enabled monitoring solution suite aids in driving innovation across the care continuum and supports decentralized clinical trials.
• In September 2020, AliveCor announced its entry into India, with the launch of the KardiaMobile 6L, a scientifically approved personal ECG device. According to the company, the personal ECG device is the world’s only six-lead, FDA-cleared personal ECG device.
• In May 2020, Finland-based Heart2Save and Lumoava developed the ECG necklace, AiVoni Lumoava (now, Awario Gem), which delivers reliable arrhythmia analysis for self-monitoring in a stylish, unnoticeable way

Each of these players has been profiled in the ECG devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com